IngliforibAlternative Names: CP 368296
Latest Information Update: 16 Aug 2004
At a glance
- Originator Pfizer
- Class Antihyperglycaemics; Indoles; Pyrrolidines; Small molecules
- Mechanism of Action Glycogen phosphorylase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Diabetes mellitus